Key result
Current vaping (aOR 1.31; 95% CI 1.05-1.63) and concurrent smoking and vaping (aOR 1.77; 95% CI 1.32-2.39) were associated with higher odds of self-reported diagnosed hypertension.
Why the study?
Knowledge of the health consequences of e-cigarette use remains limited, and epidemiologic studies have not comprehensively explored associations between e-cigarette use and hypertension.
Are cigarette smoking and e-cigarette use associated with self-reported diagnosed hypertension in adults aged 18-55?
Cross-Sectional (n=19,147)
Are cigarette smoking and e-cigarette use associated with self-reported diagnosed hypertension in adults aged 18-55?
Odds Ratio: 1.31 (95% CI 1.05–1.63)
Both e-cigarette use and traditional cigarette smoking are independently associated with higher odds of self-reported hypertension, with dual use conferring the highest risk.
Cross-sectional vaping-hypertension association is hypothesis-generating; prospective studies required before any clinical implications.
Following their introduction a decade ago, electronic cigarettes (e-cigarettes) have grown in popularity. Given their novelty, knowledge of the health consequences of e-cigarette use remains limited. Epidemiologic studies have not comprehensively explored associations between e-cigarette use and hypertension, a highly prevalent health condition and major contributor to cardiovascular disease burden. In this study, cross-sectional associations of cigarette smoking and e-cigarette use (vaping) with self-reported diagnosed hypertension were evaluated among 19,147 18-55 year old respondents in Wave 3 (2015-2016) of the Population Assessment of Tobacco and Health Study. Multivariable analyses first modeled smoking and vaping as separate 2-category variables, then as a 6-category composite variable accounting for former smoking. After adjusting for potential confounders, current vaping (aOR = 1.31; 95%CI: 1.05-1.63) and current smoking (aOR = 1.27; 95%CI: 1.10-1.47) were both associated with higher odds of hypertension. In analyses modeling smoking and vaping compositely, respondents who were concurrently smoking and vaping had the highest odds of hypertension (aOR = 1.77; 95%CI: 1.32-2.39 [referent: never smokers]). These results differ somewhat from prior epidemiologic studies of vaping and respiratory outcomes, which consistently report smaller point estimates for current vaping than for current smoking. Our findings reinforce the uncertainty surrounding long-term health consequences of vaping, as well as highlight important distinctions between respiratory and cardiovascular outcomes when considering the harm reduction potential of e-cigarettes.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2021) conducted a cross-sectional in Hypertension (n=19,147). Current vaping vs. Never smokers was evaluated on Self-reported diagnosed hypertension (aOR 1.31, 95% CI 1.05-1.63). Current vaping (aOR 1.31; 95% CI 1.05-1.63) and concurrent smoking and vaping (aOR 1.77; 95% CI 1.32-2.39) were associated with higher odds of self-reported diagnosed hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: